{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:26:34Z","timestamp":1771676794744,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.3816\/cbc.2007.n.010","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:05:01Z","timestamp":1221080701000},"page":"550-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy: A Schedule or a Dose Issue?"],"prefix":"10.3816","volume":"7","author":[{"given":"Andrea","family":"Pace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Nistic\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cuppone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Bria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edvina","family":"Gali\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Natoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Sperduti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Jandolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Calabretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silverio","family":"Tomao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmondo","family":"Terzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2007.n.010_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01999566","article-title":"Paclitaxel neurotoxicity: clinical and neurophysiological study in 23 patients","volume":"18","author":"Pace","year":"1996","journal-title":"It J Neurol Sci"},{"key":"10.3816\/CBC.2007.n.010_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410350310","article-title":"Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies","volume":"35","author":"Chaudry","year":"1994","journal-title":"Ann Neurol"},{"key":"10.3816\/CBC.2007.n.010_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0936-6555(05)80367-X","article-title":"Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: a review","volume":"6","author":"Guchelaar","year":"1994","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.3816\/CBC.2007.n.010_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2005.06.030","article-title":"Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes","volume":"42","author":"Mielke","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.3816\/CBC.2007.n.010_bib5","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1200\/JCO.2004.08.048","article-title":"Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B trial 9342","volume":"22","author":"Winer","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.n.010_bib6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1212\/01.WNL.0000092015.03923.19","article-title":"Grading of chemotherapyinduced peripheral neurotoxicity using the total neuropathy scale","volume":"61","author":"Cavaletti","year":"2003","journal-title":"Neurology"},{"key":"10.3816\/CBC.2007.n.010_bib7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","article-title":"The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20","volume":"41","author":"Postma","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.3816\/CBC.2007.n.010_bib8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1040-8428(02)00109-9","article-title":"Weekly administration of paclitaxel: theoretical and clinical basis","volume":"44","author":"Marchetti","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.3816\/CBC.2007.n.010_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1634\/theoncologist.10-6-370","article-title":"Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy","volume":"10","author":"Norton","year":"2005","journal-title":"Oncologist"},{"key":"10.3816\/CBC.2007.n.010_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00001813-200311000-00003","article-title":"Comparative neurotoxicity of weekly non-break paclitaxel infusion over 1 versus 3 h","volume":"14","author":"Mielke","year":"2003","journal-title":"Anticancer Drugs"},{"key":"10.3816\/CBC.2007.n.010_bib11","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-05-0298","article-title":"Association of paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer","volume":"11","author":"Mielke","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CBC.2007.n.010_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1634\/theoncologist.10-9-665","article-title":"Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer","volume":"10","author":"Eniu","year":"2005","journal-title":"Oncologist"},{"key":"10.3816\/CBC.2007.n.010_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jnnp.61.4.409","article-title":"Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients","volume":"61","author":"Pace","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3816\/CBC.2007.n.010_bib14","series-title":"SF-36 Physical and Mental Summary Scales: A User's Manual","author":"Ware","year":"1994"},{"key":"10.3816\/CBC.2007.n.010_bib15","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1200\/JCO.2005.05.031","article-title":"\u201cWill weekly work\u201d? Seems to be so\u2026","volume":"23","author":"Seidman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.n.010_bib16","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1158\/0008-5472.CAN-04-2624","article-title":"Anti-angiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells","volume":"65","author":"Pasquir","year":"2005","journal-title":"Cancer Res"},{"key":"10.3816\/CBC.2007.n.010_bib17","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1200\/JCO.2005.08.119","article-title":"Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications","volume":"23","author":"Taghian","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.n.010_bib18","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1200\/JCO.2005.06.232","article-title":"Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with once-every-3-weeks paclitaxel","volume":"23","author":"Green","year":"2005","journal-title":"J Clin Oncol"},{"issue":"14 suppl","key":"10.3816\/CBC.2007.n.010_bib19","first-page":"14S","article-title":"CALGB 9840: phase III study of weekly paclitaxel via 1-hour infusion versus standard 3-hour infusion every third week in the treatment of metastatic breast cancer (MBC), with trastuzumab (T) for HER2 positive MBC and randomized for T in HER2 normal MBC","volume":"22","author":"Seidman","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.n.010_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000086975","article-title":"Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II study","volume":"68","author":"Nistic\u00f2","year":"2005","journal-title":"Oncology"},{"key":"10.3816\/CBC.2007.n.010_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000074475","article-title":"Phase II trial of weekly paclitaxel in previously untreated advanced non-small-cell lung cancer","volume":"65","author":"Yasuda","year":"2003","journal-title":"Oncology"},{"key":"10.3816\/CBC.2007.n.010_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000079481","article-title":"Phase II study of weekly paclitaxel in patients with non-small cell lung cancer who have failed previous treatments","volume":"66","author":"Yasuda","year":"2004","journal-title":"Oncology"},{"key":"10.3816\/CBC.2007.n.010_bib23","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1200\/JCO.1998.16.10.3353","article-title":"Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer","volume":"16","author":"Seidman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.n.010_bib24","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1200\/JCO.2001.19.22.4216","article-title":"Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer","volume":"19","author":"Perez","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.n.010_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/02841860310017748","article-title":"Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer","volume":"43","author":"Wist","year":"2004","journal-title":"Acta Oncol"},{"key":"10.3816\/CBC.2007.n.010_bib26","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/cncr.11375","article-title":"Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B","volume":"97","author":"Akerley","year":"2003","journal-title":"Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911707480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911707480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:10:25Z","timestamp":1761513025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911707480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1526820911707480"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2007.n.010","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy: A Schedule or a Dose Issue?","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2007.n.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}